| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.52B | 1.52B | 1.53B | 1.95B | 1.68B |
| Gross Profit | 173.64M | 152.94M | 165.09M | 314.48M | 274.12M |
| EBITDA | 142.65M | 133.06M | 149.72M | 297.93M | 255.48M |
| Net Income | 49.29M | 44.15M | 54.62M | 171.89M | 139.79M |
Balance Sheet | |||||
| Total Assets | 1.71B | 1.59B | 1.50B | 1.50B | 1.31B |
| Cash, Cash Equivalents and Short-Term Investments | 19.77M | 19.56M | 29.77M | 30.98M | 15.10M |
| Total Debt | 380.56M | 348.89M | 266.01M | 230.04M | 271.71M |
| Total Liabilities | 890.93M | 820.27M | 756.78M | 757.15M | 710.81M |
| Stockholders Equity | 815.22M | 774.65M | 739.24M | 738.18M | 601.19M |
Cash Flow | |||||
| Free Cash Flow | 6.42M | 1.69M | 10.17M | 184.15M | 162.04M |
| Operating Cash Flow | 122.86M | 135.41M | 117.55M | 273.60M | 218.85M |
| Investing Cash Flow | -122.61M | -142.90M | -110.90M | -189.27M | -67.56M |
| Financing Cash Flow | -47.00K | -2.71M | -7.87M | -68.44M | -146.79M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | $723.76M | -945.28 | -0.13% | ― | 12.49% | 95.48% | |
64 Neutral | $481.29M | 9.93 | 6.20% | 3.81% | -5.05% | 35.01% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | $480.43M | -1.64 | -78.11% | ― | -9.75% | -386.63% | |
51 Neutral | $1.14B | -2.43 | -29.57% | 8.27% | -7.81% | -334.15% | |
49 Neutral | $678.10M | -4.03 | -187.23% | ― | 147.78% | -137.42% | |
40 Underperform | $22.99M | -0.32 | -21.13% | ― | -28.47% | 16.83% |
On February 20, 2026, AdvanSix reported fourth-quarter and full-year 2025 results showing modest top-line growth and margin improvement despite challenging market conditions. Full-year 2025 sales were $1.52 billion, essentially flat year on year, while net income rose to $49.3 million and adjusted EBITDA increased to $156.8 million, supported by stronger plant nutrients demand, record ammonia and sulfuric acid production, and disciplined capital spending that lifted free cash flow.
Fourth-quarter 2025 sales climbed 9% to $360 million on an 11% volume increase tied to the prior year’s extended turnaround, though the company posted a small net loss of $2.8 million with adjusted EPS of $0.03. Management highlighted successful completion of 2025 plant turnarounds at the low end of cost expectations and outlined actions to drive improved cash generation in 2026 via fixed-cost savings, tighter turnaround scope and risk-based capital allocation, reinforcing its conservative leverage profile and ongoing dividend program.
Also on February 20, 2026, the board declared a cash dividend of $0.16 per share, payable March 23, 2026 to shareholders of record on March 9, 2026. The payout underscores AdvanSix’s intention to preserve a competitive dividend while navigating cyclical trough conditions in nylon, mixed intermediates pricing and robust yet cost-intensive plant nutrients markets.
The most recent analyst rating on (ASIX) stock is a Hold with a $16.50 price target. To see the full list of analyst forecasts on AdvanSix stock, see the ASIX Stock Forecast page.
On December 22, 2025, AdvanSix announced that it had appointed Jeffrey J. Bird as an independent member of its Board of Directors, effective January 1, 2026, a move that expands the board to ten members, nine of whom are independent under New York Stock Exchange standards. Bird, currently Interim President and Chief Operating Officer of Envent Corporation and a director at methane-detection specialist Heath Consultants, brings extensive executive experience in global manufacturing and chemicals, as well as deep financial, operational and governance expertise from senior roles at Dril-Quip, Frank’s International, Ascend Performance Materials and Danaher. He will serve on AdvanSix’s Audit Committee and its Health, Safety and Environmental Committee, and the company’s leadership underscored that his appointment is intended to strengthen strategic oversight, reinforce governance around safety and sustainability, and support AdvanSix’s efforts to deliver resilient performance, long-term growth and enhanced shareholder value.
The most recent analyst rating on (ASIX) stock is a Hold with a $16.00 price target. To see the full list of analyst forecasts on AdvanSix stock, see the ASIX Stock Forecast page.